In oncology, persistent activation of STAT proteins promotes tumor cell proliferation and survival, fosters a pro-tumor inflammatory microenvironment, and suppresses antitumor immunity (Li et al., 2023). This evidence concerns the gene SOAT1 and neoplasm.